Episodic Migraine (DBCOND0041253)

Identifiers

Synonyms
Migraine Headache, Episodic / Episodic Migraine Headache / Episodic migraine / Episodic migraine (disorder) / Migraine, unspecified / Migraine, unspecified, not intractable, without status migrainosus / Migraine NOS / Migraine headaches / Migraine headache / Migrainous headache / Migraine type headaches / Migraine Disorders / Migraine (disorder) / Migraine

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Atogepant
An oral CGRP antagonist used for the preventative therapy of episodic migraine headaches.
Rimegepant
An oral CGRP receptor antagonist used for the acute treatment of migraines with or without aura in adults.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migrainetreatment3recruiting
NCT05897320
A Study of Eptinezumab in Pediatric Participants With Episodic Migrainetreatment3recruiting
NCT06625060
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in AdultsNo drug interventionstreatment2recruiting
NCT05264129
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migrainetreatment4completed
NCT06603558
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic MigraineNot AvailableNot Availablerecruiting
NCT06047457
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adultsprevention3recruiting
NCT06051604
Mi-Helper Transnasal Cooling for Acute Treatment of MigraineNo drug interventionstreatmentNot Availablecompleted
NCT04437433
A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migrainetreatment3completed
NCT03132233
Energy for the BrainNo drug interventionspreventionNot Availablecompleted
NCT04166045
Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine PainNo drug interventionstreatmentNot Availablecompleted
NCT04936061
Transnasal Cooling for MigraineNo drug interventionstreatmentNot Availableterminated
NCT01230411
Pilot Study to Collect and Evaluate Data on the Use of IV* Ibuprofen in the Treatment of an Acute Migraine Attacktreatment4completed
NCT06004388
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)No drug interventionstreatment3active_not_recruiting
NCT03333109
Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patientsprevention3completed
NCT00868556
fMRI of the Brainstem in Migraine Sufferers and Controls. Does Iron Deposition Correlate With Progression of Disease?No drug interventionsNot AvailableNot Availablecompleted
NCT06562400
Searching for Novel Therapeutic Approaches in Migraine Patients Resistant to TreatmentsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05853900
Study of Two Digital Therapeutics for the Prevention of Episodic MigraineNo drug interventionstreatment3completed
NCT05281770
Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life StudyNot AvailableNot Availablerecruiting
NCT03096834
A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapiesprevention3completed
NCT00719134
The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headachebasic_science4completed
NCT03432286
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migrainetreatment3recruiting
NCT05207865
Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Preventiontreatment4completed
NCT04740827
Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.treatment3completed
NCT05742191
The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches.No drug interventionsNot AvailableNot Availablerecruiting
NCT04628429
CGRP Inhibition, Autonomic Function, and MigraineNot AvailableNot Availablerecruiting
NCT05210192
Sphenopalatine Ganglion Blockade in Migrainetreatment3unknown_status
NCT06155123
HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbsNot AvailableNot Availablerecruiting
NCT02569853
DFN-11 Injection in Episodic Migraine With or Without AuraNo drug interventionstreatment3completed
NCT05449145
The Effects of Vitamin D Plus Omega-3 Polyunsaturated Fatty Acids in Patients With Episodic MigraineNo drug interventionspreventionNot Availablerecruiting
NCT01257893
Aspirin Resistance in Women With MigrainescreeningNot Availablewithdrawn
NCT06248671
Prophylactic Treatment With Atorvastatin for Episodic Migraine.prevention2recruiting
NCT05042037
Probiotics as Adjunctive Migraine ProphylaxisNo drug interventionstreatmentNot Availablerecruiting
NCT03963232
A Study of Galcanezumab (LY2951742) in Participants With Episodic Migrainetreatment3completed
NCT05226559
Effectiveness of Multimodal Physical Therapy in MigraineNo drug interventionstreatmentNot Availablerecruiting
NCT03777059
12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraineprevention3completed
NCT06549270
Biochemical Profiling of Migraine PatientsNot AvailableNot Availablerecruiting
NCT04686136
A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migrainetreatment3active_not_recruiting
NCT06562413
Searching for Novel Biological Phenotypes in Migraine Patients Resistant to TreatmentsNot AvailableNot Availablerecruiting
NCT02176018
Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migrainetreatment2completed
NCT05454319
Cerebri Biofeedback Feasibility TrialNo drug interventionsotherNot Availablecompleted
NCT04828941
My Healthy Diary - An Electronic Diary for Remote Migraine MonitoringNo drug interventionsdiagnosticNot Availableunknown_status
NCT06229834
Chiropractic Care for Episodic MigraineNo drug interventionsotherNot Availablenot_yet_recruiting
NCT05127486
A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migrainetreatment4completed
NCT05734625
Efficacy of Nerve Blocks for Episodic Migrainetreatment2recruiting
NCT03526874
Occipital Blocks for Acute Migrainetreatment3completed
NCT03700320
Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migrainetreatment3completed
NCT03927144
Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patientstreatment4completed
NCT05028569
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraineprevention3active_not_recruiting
NCT03939312
Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migrainetreatment3completed
NCT04031781
The Role of Left Prefrontal Transcranial Magnetic Stimulation in Episodic Migraine ProphylaxisNo drug interventionspreventionNot Availablecompleted
NCT01899040
A Non-Invasive Neuromodulation Device for Treatment of Migraine HeadacheNo drug interventionstreatmentNot Availablecompleted
NCT02025556
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migrainetreatment2completed